Key result
Nine-variable LASSO model predicts prolonged length of stay in LEAD with ~0.71 test AUC.
Why the study?
To develop and internally validate a prediction model incorporating multivariable and comprehensive factors to predict prolonged length of stay in patients with lower extremity atherosclerotic disease.
Can a multivariable clinical prediction model accurately identify patients with lower extremity atherosclerotic disease at risk of a prolonged length of stay?
Cohort (n=1,694)
No
Can a multivariable clinical prediction model accurately identify patients with lower extremity atherosclerotic disease at risk of a prolonged length of stay?
Effect estimate: AUC 0.750 (training) and 0.708 (test)
A novel 9-variable clinical prediction model can help predict prolonged hospitalization in patients with LEAD, potentially optimizing bed management and resource allocation.
May support resource planning in LEAD hospitalizations; leaves open external validation and outcome impact before adoption.
OBJECTIVES: This study aims to develop and internally validate a prediction model, which takes account of multivariable and comprehensive factors to predict the prolonged length of stay (LOS) in patients with lower extremity atherosclerotic disease (LEAD). DESIGN: This is a retrospective study. SETTING: China. PARTICIPANTS, PRIMARY AND SECONDARY OUTCOMES: Data of 1694 patients with LEAD from a retrospective cohort study between January 2014 and November 2021 were analysed. We selected nine variables and created the prediction model using the least absolute shrinkage and selection operator (LASSO) regression model after dividing the dataset into training and test sets in a 7:3 ratio. Prediction model performance was evaluated by calibration, discrimination and Hosmer-Lemeshow test. The effectiveness of clinical utility was estimated using decision curve analysis. RESULTS: LASSO regression analysis identified age, gender, systolic blood pressure, Fontaine classification, lesion site, surgery, C reactive protein, prothrombin time international normalised ratio and fibrinogen as significant predictors for predicting prolonged LOS in patients with LEAD. In the training set, the prediction model showed good discrimination using a 500-bootstrap analysis and good calibration with an area under the receiver operating characteristic of 0.750. The Hosmer-Lemeshow goodness of fit test for the training set had a p value of 0.354. The decision curve analysis showed that using the prediction model both in training and tests contributes to clinical value. CONCLUSION: Our prediction model is a valuable tool using easily and routinely obtained clinical variables that could be used to predict prolonged LOS in patients with LEAD and help to better manage these patients in routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) conducted a cohort in Lower extremity atherosclerotic disease (LEAD) (n=1,694). Clinical predictors (age, gender, systolic blood pressure, Fontaine classification, lesion site, surgery, CRP, PT-INR, and fibrinogen) was evaluated on Prolonged length of stay (>10 days) (AUC 0.750 (training) and 0.708 (test)). A LASSO-derived multivariable prediction model incorporating nine clinical variables effectively predicted prolonged length of stay in patients with LEAD, with an AUC of 0.750 in the training set and 0.708 in the test set.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: